Final results of neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER).
Saved in:
| Title: | Final results of neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER). |
|---|---|
| Authors: | Fernandez, M., Calvo, I., Martinez, N., Herrero, M., Quijano, Y., Duran, H., Garcia-Aranda, M., Suarez, A., Lopez-Rios, F., Perez, D., Perea, S., Hidalgo, M., Garcia-Estevez, L. |
| Source: | Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p396-397. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 86071850 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Final results of neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Fernandez%2C+M%2E%22">Fernandez, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Calvo%2C+I%2E%22">Calvo, I.</searchLink><br /><searchLink fieldCode="AR" term="%22Martinez%2C+N%2E%22">Martinez, N.</searchLink><br /><searchLink fieldCode="AR" term="%22Herrero%2C+M%2E%22">Herrero, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Quijano%2C+Y%2E%22">Quijano, Y.</searchLink><br /><searchLink fieldCode="AR" term="%22Duran%2C+H%2E%22">Duran, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Garcia-Aranda%2C+M%2E%22">Garcia-Aranda, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Suarez%2C+A%2E%22">Suarez, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Lopez-Rios%2C+F%2E%22">Lopez-Rios, F.</searchLink><br /><searchLink fieldCode="AR" term="%22Perez%2C+D%2E%22">Perez, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Perea%2C+S%2E%22">Perea, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Hidalgo%2C+M%2E%22">Hidalgo, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Garcia-Estevez%2C+L%2E%22">Garcia-Estevez, L.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Research%22">Cancer Research</searchLink>. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p396-397. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=86071850 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/0008-5472.SABCS12-P1-14-10 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: 396 Titles: – TitleFull: Final results of neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fernandez, M. – PersonEntity: Name: NameFull: Calvo, I. – PersonEntity: Name: NameFull: Martinez, N. – PersonEntity: Name: NameFull: Herrero, M. – PersonEntity: Name: NameFull: Quijano, Y. – PersonEntity: Name: NameFull: Duran, H. – PersonEntity: Name: NameFull: Garcia-Aranda, M. – PersonEntity: Name: NameFull: Suarez, A. – PersonEntity: Name: NameFull: Lopez-Rios, F. – PersonEntity: Name: NameFull: Perez, D. – PersonEntity: Name: NameFull: Perea, S. – PersonEntity: Name: NameFull: Hidalgo, M. – PersonEntity: Name: NameFull: Garcia-Estevez, L. IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 12 Text: Dec2012 Meeting Abstracts Type: published Y: 2012 Identifiers: – Type: issn-print Value: 00085472 Numbering: – Type: volume Value: 72 – Type: issue Value: 24a Titles: – TitleFull: Cancer Research Type: main |
| ResultId | 1 |
